Published on Wednesday February 05, 2025

Smooth Drug Development January 2025 News Release

Monthly News – January 2025

At Smooth Drug Development, we are excited to share the latest updates and achievements from January 2025:

New Projects

We are delighted to announce several new collaborations:

  • Signed contracts for a Phase I study for medical writing services with Daratumumab and a bioequivalence study with Azithromycin.
  • Secured a contract to write abstracts and posters based on the results of the Venetoclax study.

Clinical and Scientific Departments News:

Our clinical teams continue to deliver outstanding progress:

  • Independent audits were successfully conducted in the Phase II trial in flu.
  • The international phase III clinical trial of the original drug for patients with chronic myeloid leukemia reported results after one year of treatment.
  • 92 patients were enrolled in the Pembrolizumab trial.

Business Development News:

Our Business Development team ended the year with active participation in key industry events:

  • Our team will attend the Clinical Trials Summit of Pakistan in February 2025.
  • We have launched our official Telegram channel. Please join us for the latest updates.

Thank you for your continued support and interest in Smooth Drug Development. Stay tuned for more updates next month as we continue to push the boundaries of excellence in clinical research!